Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma

Figure 3 miR-382 expression levels were reverse-correlated with esophageal squamous cell carcinoma patient survival times. A: The esophageal squamous cell carcinoma (ESCC) with higher miR-382 expression generally exhibited longer survival times, compared to those with lower expression levels (P < 0.001, higher vs lower miR-382 level); B: Stage I ESCC patients with higher levels of miR-382 exhibited longer survival times, compared to those with lower expression levels (P < 0.01, higher vs lower miR-382 level); C: Stage II ESCC patients with higher levels of miR-382 exhibited longer survival times, compared to those with lower expression levels (P < 0.01, higher vs lower miR-382 level); D: Stage III ESCC patients with higher levels of miR-382 exhibited longer survival times, compared to those with lower expression levels (P < 0.01, higher vs lower miR-382 level).